Autoimmune thyroid disease: further developments in our understanding.

The revolution in molecular techniques has allowed dissection of the autoimmune response in a way impossible to imagine 10 yr ago. There have been spectacular advances in our understanding of self-tolerance mechanisms and how these may fail, combined with a detailed comprehension of antigen presentation, functional T cell subsets, and TCR utilization in autoimmunity, albeit usually in animal models that resemble, but do not exactly duplicate, human diseases. More gradually, these findings are being translated to thyroid autoimmunity, where the major achievement of the last decade has been the molecular characterization of the three main thyroid autoantigens. This in turn has allowed epitope identification, although again the only clear data so far have come from animal models of EAT. Another advance has been the recognition that the thyrocyte is not a helpless target of autoaggression, being capable of expressing a wide array of immunologically active molecules, which may exacerbate or diminish the autoimmune response. In 1983, there was considerable excitement at the discovery of the first of these phenomena, namely MHC class II expression, but its possible role in autoantigen presentation remains to be defined. By analogy with pancreatic beta-cells, and based on our own data, we believe that class II-expressing thyrocytes have little, if any, such role and suspect that instead this may be a mechanism for inducing peripheral tolerance. Defining the contribution of thyrocytes to the intrathyroidal autoimmune response, whether from released cytokines or surface-bound molecules, will be crucial to our future understanding, as well as holding the promise that these thyroid-derived products might be therapeutic targets. Despite molecular developments in HLA analysis, there have been no really major improvements in our understanding of the immunogenetics of thyroid autoimmunity, equivalent to those made in type 1 diabetes mellitus. The available data suggest strongly that non-MHC genes play an important role in susceptibility, and novel approaches will be required to identify these. On the other hand, we know more about the importance of environmental and endogenous (most probably hormonal) factors in thyroid autoimmunity. Understanding the basic immunological changes in the postpartum period is still poor, however, as most studies to date have concentrated on epidemiology and clinical delineation. As PPTD undergoes spontaneous remission, elucidation of these mechanisms has clear implications for treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  K. Hála Hypothesis: immunogenetic analysis of spontaneous autoimmune thyroiditis in obese strain (OS) chickens: a two-gene family model. , 1988, Immunobiology.

[2]  J. Mckenzie,et al.  Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. , 1992, Thyroid : official journal of the American Thyroid Association.

[3]  P. Perros,et al.  Age and gender influence the severity of thyroid‐associated ophthalmopathy: a study of 101 patients attending a combined thyroid‐eye clinic , 1993, Clinical endocrinology.

[4]  L. Hegedüs,et al.  Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis. , 1990, Acta endocrinologica.

[5]  A. Weetman,et al.  IgG heavy‐chain subclass restriction of thyrotropin‐binding inhibitory immunoglobulins in Graves' disease , 1990, European journal of clinical investigation.

[6]  C. Gorman,et al.  Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease. , 1991, The Journal of clinical endocrinology and metabolism.

[7]  U. Forsum,et al.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. , 1984, Clinical and experimental immunology.

[8]  D. Russo,et al.  Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor. , 1991, Molecular endocrinology.

[9]  D. Mason,et al.  Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential , 1993, The Journal of experimental medicine.

[10]  W. Alexander,et al.  A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. , 1993, The Journal of clinical endocrinology and metabolism.

[11]  C. Marcocci,et al.  More on smoking habits and Graves’ ophthalmopathy , 1989, Journal of endocrinological investigation.

[12]  S. McLachlan,et al.  Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. , 1990, Acta endocrinologica.

[13]  N. Rose,et al.  Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. , 1990, Clinical immunology and immunopathology.

[14]  A. Foulis,et al.  Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon‐gamma‐containing lymphocytes in human thyroid autoimmune disease , 1991, Clinical and experimental immunology.

[15]  H. Drexhage,et al.  Intrathyroidal dendritic cells. , 1988, The Journal of clinical endocrinology and metabolism.

[16]  A. Shenker,et al.  Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.

[17]  P. Fells,et al.  Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. , 1989, Clinical and experimental immunology.

[18]  J. Rootman,et al.  The initial clinical characteristics of Graves' orbitopathy vary with age and sex. , 1993, Archives of ophthalmology.

[19]  R. Sobel,et al.  Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis. , 1993, Journal of immunology.

[20]  W. Clarke,et al.  Autoimmunity in congenital rubella syndrome. , 1984, The Journal of pediatrics.

[21]  M. Kaplan,et al.  Monitoring thyroxine treatment during pregnancy. , 1992, Thyroid : official journal of the American Thyroid Association.

[22]  J. Charreire Immune mechanisms in autoimmune thyroiditis. , 1989, Advances in immunology.

[23]  P. Fells,et al.  T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy. , 1989, The British journal of ophthalmology.

[24]  H. Inoko,et al.  Apparent genetic difference between hypothyroid patients with blocking-type thyrotropin receptor antibody and those without, as shown by restriction fragment length polymorphism analyses of HLA-DP loci. , 1993, The Journal of clinical endocrinology and metabolism.

[25]  A. Cooke,et al.  Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis , 1988, European journal of immunology.

[26]  A. Fauci,et al.  The in vitro regulation of human thyrocyte HLA-DR antigen expression. , 1985, The Journal of clinical endocrinology and metabolism.

[27]  A. Nishio,et al.  Effects of intrathymic injection of organ‐specific autoantigens, parietal cells, at the neonatal stage on autoreactive effector and suppressor T cell precursors , 1993, European journal of immunology.

[28]  E. Milgrom,et al.  Composite structure of the human thyrotropin receptor gene. , 1991, Biochemical and biophysical research communications.

[29]  E. Milgrom,et al.  Two-subunit structure of the human thyrotropin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Keast,et al.  The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. , 1983, Endocrinology.

[31]  K. Burman,et al.  Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. , 1988, Annals of internal medicine.

[32]  A. Weetman,et al.  Analysis of fibroblast-stimulating activity in IgG from patients with Graves' dermopathy. , 1993, Thyroid : official journal of the American Thyroid Association.

[33]  C. Eastman,et al.  ENDEMIC CRETINISM: POSSIBLE ROLE FOR THYROID AUTOIMMUNITY , 1989, The Lancet.

[34]  A. Mcgregor Heat shock proteins and autoimmune thyroid disease; too hot to handle? , 1992, The Journal of clinical endocrinology and metabolism.

[35]  J. Banga,et al.  Immunological and molecular characteristics of the thyroid peroxidase autoantigen. , 1991, Autoimmunity.

[36]  A. McGregor,et al.  Autoimmune thyroid disease: developments in our understanding. , 1984, Endocrine reviews.

[37]  G. Shearer,et al.  Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. Characterization of thyroiditis-inducing T cell lines and clones derived from thyroid lesions. , 1993, Journal of immunology.

[38]  S. Nagataki,et al.  Follow‐Up Study Of Thyroid Stimulating‐Blocking Antibodies In Hypothyroid Patients , 1990, Clinical endocrinology.

[39]  J. Wall,et al.  Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. , 1990, The Journal of clinical endocrinology and metabolism.

[40]  M. Yamakawa,et al.  Immunohistochemical study of intrathyroidal lymph follicles. , 1987, Clinical immunology and immunopathology.

[41]  D. Glinoer,et al.  Regulation of maternal thyroid during pregnancy. , 1990, The Journal of clinical endocrinology and metabolism.

[42]  N. Bagchi,et al.  Induction of autoimmune thyroiditis in chickens by dietary iodine. , 1985, Science.

[43]  Increased need for thyroxine during pregnancy in women with primary hypothyroidism. , 1990, The New England journal of medicine.

[44]  C. Gorman,et al.  Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. , 1989, The Journal of clinical endocrinology and metabolism.

[45]  S. Ratanachaiyavong,et al.  C4A gene deletion: association with Graves' disease. , 1989, Journal of molecular endocrinology.

[46]  D. Barker,et al.  Fetal growth and autoimmune thyroid disease. , 1993, The Quarterly journal of medicine.

[47]  A. Weetman,et al.  No restriction of intrathyroidal T cell receptor Vα families in the thyroid of Graves’disease , 1993 .

[48]  Marlsol Tellez,et al.  Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin , 1992, Clinical endocrinology.

[49]  H. Drexhage,et al.  Reversible thyroid dysfunction during treatment with GM-CSF , 1991, The Lancet.

[50]  R. Tubbs,et al.  Investigation of the clonality of lymphocytes in Hashimoto's thyroiditis using immunoglobulin and T-cell receptor gene probes. , 1989, Clinical immunology and immunopathology.

[51]  M. Murakami,et al.  Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease. , 1990, Biochemical and biophysical research communications.

[52]  T. Kotani,et al.  Experimental murine thyroiditis induced by porcine thyroid peroxidase and its transfer by the antigen‐specific T cell line , 1990, Clinical and experimental immunology.

[53]  N. Farid,et al.  Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4. , 1985, Immunology letters.

[54]  G. Canonica,et al.  Proliferation of T8-positive cytolytic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis: analysis of cell interactions and culture requirements. , 1985, Clinical immunology and immunopathology.

[55]  B. Rapoport,et al.  Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. , 1992, The Journal of clinical endocrinology and metabolism.

[56]  N. Neu,et al.  Target organ susceptibility and autoantibody production in an animal model of spontaneous autoimmune thyroiditis. , 1992, Autoimmunity.

[57]  A. Weetman,et al.  Sequential analysis of experimental autoimmune thyroiditis induced by neonatal thymectomy in the Buffalo strain rat. , 1988, Cellular immunology.

[58]  E. Leiter,et al.  The genetics and epidemiology of diabetes in NOD mice. , 1990, Immunology today.

[59]  D. I. Phillips,et al.  A LONG‐TERM FOLLOW‐UP OF POSTPARTUM THYROIDITIS , 1990, Clinical endocrinology.

[60]  C. Gorman,et al.  Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. , 1991, The Journal of clinical endocrinology and metabolism.

[61]  M. Feldmann,et al.  Analysis of T-cell receptor usage in activated T-cell clones from Hashimoto's thyroiditis and Graves' disease. , 1989, Journal of autoimmunity.

[62]  T. Mori,et al.  Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies. , 1993, The Journal of clinical endocrinology and metabolism.

[63]  J. Banga,et al.  Affinity Purification of IgG Subclasses and the Distribution of Thyroid Auto‐Antibody Reactivity in Hashimoto's Thyroiditis , 1989, Scandinavian journal of immunology.

[64]  S. McLachlan,et al.  Human monoclonal thyroglobulin autoantibodies of high affinity. I. Production, characterisation and interaction with murine monoclonal thyroglobulin antibodies. , 1991, Autoimmunity.

[65]  C. Gahmberg,et al.  The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells. , 1992, Clinical immunology and immunopathology.

[66]  A. Weetman,et al.  Analysis of anti-idiotypic antibodies against anti-microsomal antibodies in patients with thyroid autoimmunity. , 1992, Journal of autoimmunity.

[67]  A. Weetman,et al.  Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. , 1994, The Quarterly journal of medicine.

[68]  J. Kriss,et al.  Biological activity of autoantibodies associated with Graves' dermopathy. , 1989, The Journal of clinical endocrinology and metabolism.

[69]  N. Rose,et al.  Quantitative measurement of human thyroglobulin-specific antibodies by use of a sensitive enzyme-linked immunoassay. , 1993, Clinical immunology and immunopathology.

[70]  G. Kroemer,et al.  Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. , 1993, Endocrine reviews.

[71]  Y. Shong,et al.  Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins. , 1989, Acta endocrinologica.

[72]  A. Weetman,et al.  Regulation of major histocompatibility complex class II antigen expression by the FRTL-5 rat thyroid cell line. , 1987, The Journal of endocrinology.

[73]  P. M. Thompson,et al.  Association between thyroid microsomal antibodies of subclass IgG-1 and hypothyroidism in autoimmune postpartum thyroiditis. , 1986, Clinical and experimental immunology.

[74]  A. Weetman,et al.  T cell receptor phenotypes in autoimmune thyroid disease , 1990, Journal of endocrinological investigation.

[75]  Y. Kohno,et al.  Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis. , 1988, Journal of immunology.

[76]  M. Zakarija Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. , 1983, Journal of clinical & laboratory immunology.

[77]  M. Devey,et al.  Serial studies on the affinity and heterogeneity of human autoantibodies to thyroglobulin. , 1989, Clinical and experimental immunology.

[78]  M. Parmentier,et al.  Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. , 1990, Biochemical and biophysical research communications.

[79]  U. Bogner,et al.  Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis. , 1990, Acta Endocrinologica.

[80]  M. Zou,et al.  Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles. , 1992, The Journal of clinical endocrinology and metabolism.

[81]  N. Rose,et al.  Antigen‐Specific Immunoregulation and Autoimmune Thyroiditis a , 1991, Annals of the New York Academy of Sciences.

[82]  R. Jansson,et al.  EVIDENCE THAT ANTITHYROID DRUGS INDUCE REMISSIONS IN GRAVEs' DISEASE BY MODULATING THYROID CELLULAR ACTIVITY , 1986, Clinical endocrinology.

[83]  A. Heufelder,et al.  Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves’ ophthalmopathy , 1993, Clinical and experimental immunology.

[84]  P. Walfish,et al.  Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. , 1988, The Journal of clinical endocrinology and metabolism.

[85]  P. Meroni,et al.  The effects of a monoclonal antibody to interferon‐γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT‐specific T cells , 1993, European journal of immunology.

[86]  G. Bottazzo,et al.  Adhesion molecule expression in Graves' thyroid glands; potential relevance of granule membrane protein (GMP‐140) and intercellular adhesion molecule‐1 (ICAM‐1) in the homing and antigen presentation processes , 1992, Clinical and experimental immunology.

[87]  Junya Chen,et al.  HLA and hypertrophic Hashimoto's thyroiditis in Shanghai Chinese. , 1988, Tissue antigens.

[88]  A. Ben-nun,et al.  Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. , 1991, The New England journal of medicine.

[89]  M. Feldmann,et al.  Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[90]  B. Rapoport,et al.  Molecular cloning and partial characterization of a new autoimmune thyroid disease-related antigen. , 1987, The Journal of clinical endocrinology and metabolism.

[91]  M. Parmentier,et al.  Molecular cloning of the thyrotropin receptor. , 1989, Science.

[92]  J. Dumont,et al.  Thyrotropin activates both the cyclic AMP and the PIP2casades in CHO cells expressing the human cDNA of TSH receptor , 1990, Molecular and Cellular Endocrinology.

[93]  A. Weetman,et al.  Thyroid cells in Graves' disease and Hashimoto's thyroiditis stimulate allogeneic T cells when pretreated with phorbol ester , 1992, Clinical endocrinology.

[94]  N. Bagchi,et al.  Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens. , 1991, The Journal of clinical investigation.

[95]  B. Rapoport,et al.  The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. , 1992, Molecular endocrinology.

[96]  A. Pinchera,et al.  In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. , 1986, Clinical and experimental immunology.

[97]  N. Bernard,et al.  Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. , 1991, Thyroid : official journal of the American Thyroid Association.

[98]  K. Ichikawa,et al.  Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. , 1991, The New England journal of medicine.

[99]  D. Barker,et al.  CURRENT INCIDENCE OF THYROTOXICOSIS AND PAST PREVALENCE OF GOITRE IN 12 BRITISH TOWNS , 1984, The Lancet.

[100]  G. Gavaruzzi,et al.  Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. , 1993, Journal of Clinical Endocrinology and Metabolism.

[101]  R. Roberts,et al.  Postpartum lymphocytic thyroiditis. Prevalence, clinical course, and long-term follow-up. , 1987, Archives of internal medicine.

[102]  M. Prummel,et al.  Smoking and risk of Graves' disease. , 1993, JAMA.

[103]  L. Braverman,et al.  Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. , 1971, The Journal of clinical endocrinology and metabolism.

[104]  A. Cooke,et al.  An investigation of the nature of induced suppression to experimental autoimmune thyroiditis. , 1988, Immunology.

[105]  Lori S. Levin,et al.  Graves exophthalmos unrelated to extraocular muscle enlargement. Superior rectus muscle inflammation may induce venous obstruction. , 1991, Ophthalmology.

[106]  M. Dorf,et al.  The effects of phorbol ester on alloantigen presentation. , 1987, Journal of immunology.

[107]  T. Minegishi,et al.  Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. , 1991, Biochemical and biophysical research communications.

[108]  B. Rapoport,et al.  Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. , 1989, Biochemical and biophysical research communications.

[109]  P. Isaacson,et al.  Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. , 1988, Human pathology.

[110]  H. Inoko,et al.  Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy , 1991, Clinical endocrinology.

[111]  G. Dworacki,et al.  Expression of CD56 (NKH‐1) differentiation antigen in human thyroid epithelium , 1992, Clinical and experimental immunology.

[112]  Y. Malthiéry,et al.  Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. , 1987, European journal of biochemistry.

[113]  N. Bernard,et al.  Restricted tissue reactivity of autoantibodies to a 64-kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. , 1992, Clinical immunology and immunopathology.

[114]  S. Wallenstein,et al.  Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. , 1992, The Journal of clinical endocrinology and metabolism.

[115]  A. Ben-nun,et al.  T-cell receptor V gene use in autoimmune thyroid disease: direct assessment by thyroid aspiration. , 1993, The Journal of clinical endocrinology and metabolism.

[116]  P. Byfield,et al.  Human autoantibodies to thyroglobulin are directed towards a restricted number of human specific epitopes. , 1987, Clinical and experimental immunology.

[117]  H. Gisslinger,et al.  Thyroid autoimmunity and hypothyroidism during long‐term treatment with recombinant interferon‐alpha , 1992, Clinical and experimental immunology.

[118]  Y. Iwatani,et al.  Studies of the effect of suppressor T lymphocytes on the induction of antithyroid microsomal antibody-secreting cells in autoimmune thyroid disease. , 1988, The Journal of clinical endocrinology and metabolism.

[119]  F. Akasu,et al.  Interleukin 2-activated killer cells do not mediate autologous thyrocyte lysis in autoimmune thyroid disease in vitro. , 1991, Thyroid : official journal of the American Thyroid Association.

[120]  C. Kozak,et al.  Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[121]  A. Gordin,et al.  Development of thyroid autoimmunity. , 1985, Acta endocrinologica.

[122]  N. Konno,et al.  Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations , 1993, Clinical endocrinology.

[123]  D. Russo,et al.  Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. , 1991, The Journal of clinical investigation.

[124]  R. Small Enlargement of levator palpebrae superioris muscle fibers in Graves' ophthalmopathy. , 1989, Ophthalmology.

[125]  B. Smith,et al.  PREDICTION OF RELAPSE IN HYPERTHYROID GRAVES' DISEASE , 1980, The Lancet.

[126]  S. McLachlan,et al.  Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands. , 1986, Clinical and experimental immunology.

[127]  E. Sercarz,et al.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire. , 1993, Immunology today.

[128]  B. Glaser,et al.  THYROTROPHIN RECEPTOR BLOCKING ANTIBODIES: INCIDENCE, CHARACTERIZATION AND IN‐VITRO SYNTHESIS , 1987, Clinical endocrinology.

[129]  A. Fauci,et al.  Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease. , 1985, Journal of immunology.

[130]  S. Nagataki,et al.  The incidence of thyroid stimulating blocking antibodies during the hypothyroid phase in patients with subacute thyroiditis. , 1991, The Journal of clinical endocrinology and metabolism.

[131]  N. Niesen,et al.  Role of late complement components in experimental autoimmune thyroiditis. , 1993, Clinical immunology and immunopathology.

[132]  U. Bogner,et al.  Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. , 1984, The Journal of clinical endocrinology and metabolism.

[133]  R. Holle,et al.  Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. , 1989, Acta endocrinologica.

[134]  B. Rapoport,et al.  The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. , 1992, Endocrine reviews.

[135]  M. Feldmann,et al.  Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. , 1985, Science.

[136]  H. Waldmann,et al.  Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. , 1989, Cellular immunology.

[137]  T. Seemayer,et al.  Association of spontaneous thyroiditis with the major histocompatibility complex of the rat. , 1985, Endocrinology.

[138]  L. Kohn,et al.  Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. , 1993, Molecular endocrinology.

[139]  S. Nagataki,et al.  Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. , 1991, Thyroid : official journal of the American Thyroid Association.

[140]  K. Ichikawa,et al.  Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. , 1992, The Journal of clinical endocrinology and metabolism.

[141]  B. Morgan,et al.  Thyroid follicular cell function after non‐lethal complement membrane attack , 1990, Clinical and experimental immunology.

[142]  A. Weetman,et al.  T cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease , 1991, Clinical and experimental immunology.

[143]  A. Weetman,et al.  HLA Associations with Hashimoto's thyroiditis , 1991, Clinical endocrinology.

[144]  G. Carayanniotis,et al.  Identification of a thyroiditogenic sequence within the thyroglobulin molecule. , 1992, Journal of immunology.

[145]  M. Mucci,et al.  Thyroid autoimmunity in hyperprolactinaemic disorders. , 1983, Acta endocrinologica.

[146]  R. Bright-Thomas,et al.  Regulation of interleukin-6 release by human thyrocytes. , 1990, The Journal of endocrinology.

[147]  A. Taube,et al.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. , 1992, The New England journal of medicine.

[148]  L. Braverman,et al.  The Effect of Methimazole on the Development of Spontaneous Lymphocytic Thyroiditis in the Diabetes‐Prone BB/W Rat , 1986, The American journal of the medical sciences.

[149]  L. Wartofsky,et al.  Graves' ophthalmopathy: current concepts regarding pathogenesis and management. , 1993, Endocrine reviews.

[150]  K. Usadel,et al.  HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. , 1992, Autoimmunity.

[151]  S. Nussey,et al.  The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotrophin receptor , 1992, Molecular and Cellular Endocrinology.

[152]  P. Perros,et al.  DIFFERENTIATION OF AUTOIMMUNE OPHTHALMOPATHY FROM GRAVES’HYPERTHYROIDISM BY ANALYSIS OF GENETIC MARKERS , 1988, Clinical endocrinology.

[153]  M. Iitaka,et al.  Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression. , 1988, The Journal of clinical endocrinology and metabolism.

[154]  A. McGregor,et al.  Transient post-partum thyroid dysfunction and postnatal depression. , 1989, Journal of affective disorders.

[155]  I. Fentiman,et al.  PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER , 1985, The Lancet.

[156]  G. Air,et al.  Epitopes on protein antigens: Misconceptions and realities , 1990, Cell.

[157]  A. Weetman,et al.  Serological analysis of experimental autoimmune thyroiditis in the buffalo strain rat. , 1990, International archives of allergy and applied immunology.

[158]  B. Champion,et al.  Critical role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. , 1987, Journal of immunology.

[159]  C. Bedin,et al.  Protection from experimental autoimmune thyroiditis conferred by a monoclonal antibody to T cell receptor from a cytotoxic hybridoma specific for thyroglobulin. , 1992, Journal of immunology.

[160]  M. Parmentier,et al.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. , 1989, Biochemical and biophysical research communications.

[161]  Y. Kohno,et al.  Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. III. Analysis of regulatory cells suppressing the induction of thyroiditis. , 1990, International immunology.

[162]  R. Pujol-Borrell,et al.  Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA. , 1992, Journal of autoimmunity.

[163]  S. Nagataki,et al.  Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript. , 1992, Biochemical and biophysical research communications.

[164]  A. Weetman,et al.  IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease. Analysis of V alpha transcript microheterogeneity. , 1993, Journal of immunology.

[165]  D. Glinoer,et al.  Current trends in the management of Graves' disease. , 1990, The Journal of clinical endocrinology and metabolism.

[166]  J. Lazarus,et al.  Iodine metabolism in postpartum thyroiditis. , 1992, Thyroid : official journal of the American Thyroid Association.

[167]  J. Konishi,et al.  Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. , 1980, The New England journal of medicine.

[168]  P. Unger,et al.  Preservation of functioning human thyroid organoids in the scid mouse: II. Biased use of intrathyroidal T cell receptor V genes. , 1993, The Journal of clinical endocrinology and metabolism.

[169]  Y. Kong,et al.  Resistance to experimental autoimmune thyroiditis is correlated with the duration of raised thyroglobulin levels. , 1992, Clinical immunology and immunopathology.

[170]  N. Farid,et al.  GENETIC FACTORS IN GRAVES' OPHTHALMOPATHY , 1986, Clinical endocrinology.

[171]  K. Burman,et al.  Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis. , 1988, The Journal of clinical endocrinology and metabolism.

[172]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[173]  D. Russo,et al.  Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor. , 1992, Molecular endocrinology.

[174]  J. Margolick,et al.  Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. , 1988, Clinical immunology and immunopathology.

[175]  A. Cooke,et al.  Epitope specificity of spontaneous and induced thyroglobulin autoantibodies in the rat. , 1988, Clinical and experimental immunology.

[176]  D. Russo,et al.  A new structural model for the thyrotropin (TSH) receptor, as determined by covalent cross-linking of TSH to the recombinant receptor in intact cells: evidence for a single polypeptide chain. , 1991, Molecular endocrinology.

[177]  J. Szabó,et al.  Do heat shock proteins play a role in Graves' disease? Heat shock protein-specific T-cells from Graves' disease thyroids do not recognize thyroid epithelial cells. , 1993, The Journal of clinical endocrinology and metabolism.

[178]  L. Braverman,et al.  The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. , 1986, Endocrinology.

[179]  H. Adami,et al.  Stressful life events and Graves' disease , 1991, The Lancet.

[180]  T. Endo,et al.  Thyrotropin receptor in non-thyroid tissues. , 1993, Biochemical and biophysical research communications.

[181]  M. Atkins,et al.  Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. , 1988, The New England journal of medicine.

[182]  H. Weiner,et al.  Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[183]  H. Gerstein,et al.  Thyrocyte HLA-DR Expression and Interferon-γProduction in Autoimmune Thyroid Disease , 1986 .

[184]  P. D. Bewsher,et al.  ANTITHYROID DRUGS IN THE TREATMENT OF HYPERTHYROIDISM OF Graves' DISEASE: LONG‐TERM FOLLOW‐UP OF 434 PATIENTS , 1989, Clinical endocrinology.

[185]  A. Weetman,et al.  ANALYSIS OF HLA‐DQB AND HLA‐DPB ALLELES IN Graves'DISEASE BY OLIGONUCLEOTIDE PROBING OF ENZYMATICALLY AMPLIFIED DNA , 1990, Clinical endocrinology.

[186]  M. Feldmann,et al.  Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseases. , 1990, Journal of autoimmunity.

[187]  K. Lam,et al.  Strong association between HLA DRw9 and Hashimoto's thyroiditis in southern Chinese. , 1987, Acta endocrinologica.

[188]  H. Waldmann,et al.  Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. , 1989, Clinical immunology and immunopathology.

[189]  J. Lazarus,et al.  Review Thyroid disease in relation to pregnancy , 1991 .

[190]  C. Gorman,et al.  Connective tissue, glycosaminoglycans, and diseases of the thyroid. , 1989, Endocrine reviews.

[191]  L. Tallstedt,et al.  Immunohistochemical staining of normal and Graves' extraocular muscle. , 1988, Investigative ophthalmology & visual science.

[192]  M. Feldmann,et al.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. , 1987, Clinical and experimental immunology.

[193]  A. Weetman,et al.  Antithyroid drugs ameliorate thymectomy-induced experimental autoimmune thyroiditis. , 1988, Autoimmunity.

[194]  A. Pinchera,et al.  Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey. , 1986, Journal of endocrinological investigation.

[195]  M. Feldmann,et al.  Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells. , 1990, Immunology.

[196]  E. Young,et al.  Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. , 1990, The Journal of clinical endocrinology and metabolism.

[197]  G. Canonica,et al.  Expression of intercellular adhesion molecule‐1 (ICAM‐1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer , 1991, Clinical and experimental immunology.

[198]  R. Harden,et al.  Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis. , 1970, The Journal of clinical endocrinology and metabolism.

[199]  R. Volpe,et al.  The immunoregulatory disturbance in autoimmune thyroid disease. , 1988, Autoimmunity.

[200]  K. Badenhoop,et al.  Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. , 1990, The Journal of clinical endocrinology and metabolism.

[201]  B. Pau,et al.  A major human thyroglobulin epitope defined with monoclonal antibodies is mainly recognized by human autoantibodies , 1992, European journal of immunology.

[202]  A. Weetman Thyroid-associated ophthalmopathy. , 1992, Autoimmunity.

[203]  H A Erlich,et al.  Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[204]  N. Bagchi,et al.  The incorporation of dietary iodine into thyroglobulin increases its immunogenicity. , 1987, Endocrinology.

[205]  R. Fauchet,et al.  Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. , 1990, The Journal of clinical endocrinology and metabolism.

[206]  F. Corstens,et al.  HYPOTHYROIDISM AND GOITRE DURING INTERLEUKIN-2 THERAPY WITHOUT LAK CELLS , 1989, The Lancet.

[207]  R. Volpe Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling: a review. , 1994, Thyroid : official journal of the American Thyroid Association.

[208]  T. Akamizu,et al.  Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. , 1992, Molecular endocrinology.

[209]  A. Weetman Autologous CD8-positive cells suppress T cell proliferation in response to thyroid antigens in Hashimoto's thyroiditis. , 1989, Clinical immunology and immunopathology.

[210]  G. Kroemer,et al.  The Obese Strain of Chickens: An Animal Model with Spontaneous Autoimmune Thyroiditis , 1989 .

[211]  T. Davies,et al.  Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo. , 1984, The Journal of clinical investigation.

[212]  R. Cone,et al.  Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. , 1992, Endocrinology.

[213]  D. Burton,et al.  Cloning of a human autoimmune response: preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach. , 1992, Autoimmunity.

[214]  F. Matsuzuka,et al.  Decreases in αβ T cell receptor negative T cells and CD8 cells, and an increase in CD4 + CD8+ cells in active Hashimoto's disease and subacute thyroiditis , 1992 .

[215]  G. Nabozny,et al.  Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis. , 1991, Cellular immunology.

[216]  D. Wynford‐Thomas,et al.  The effects of hyperthyroidism on experimental autoimmune thyroiditis in the rat. , 1985, Endocrinology.

[217]  Banga,et al.  The thyrotrophin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. , 1993, Journal of Molecular Endocrinology.

[218]  P. Unger,et al.  Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterization. , 1993, The Journal of clinical endocrinology and metabolism.

[219]  D. Russo,et al.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ. , 1993, The Journal of clinical investigation.

[220]  A. Weetman,et al.  Characterization of different types of experimental autoimmune thyroiditis in the Buffalo strain rat. , 1987, Clinical and experimental immunology.

[221]  R. Koenig,et al.  Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. , 1993, The Journal of clinical endocrinology and metabolism.

[222]  T. Davies,et al.  Thyroid-specific T cells in the normal Wistar rat. I. Characterization of lymph node T cell reactivity to syngeneic thyroid cells and thyroglobulin. , 1991, Clinical immunology and immunopathology.

[223]  Rosalind S. Brown,et al.  Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism. , 1990, The Journal of clinical endocrinology and metabolism.

[224]  P. Perros,et al.  Biological activity of autoantibodies from patients with thyroid-associated ophthalmopathy: in vitro effects on porcine extraocular myoblasts. , 1992, The Quarterly journal of medicine.

[225]  C. Osmond,et al.  Does infection initiate Graves disease? A population based 10 year study. , 1989, Autoimmunity.

[226]  N. Takasu,et al.  Graves' Disease Following Hypothyroidism Due To Hashimoto's Disease: Studies Of Eight Cases , 1990, Clinical endocrinology.

[227]  P. Laurberg,et al.  Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. , 1993, The Journal of clinical endocrinology and metabolism.

[228]  F. Karlsson,et al.  Thyroid blocking antibodies in thyroiditis. , 2009, Acta medica Scandinavica.

[229]  T. Sasazuki,et al.  Hashimoto's thyroiditis and HLA in Japanese. , 1989, The Journal of clinical endocrinology and metabolism.

[230]  L. Braverman,et al.  Iodine content of rat thyroglobulin affects its antigenicity in inducing lymphocytic thyroiditis in the BB/Wor rat. , 1992, Autoimmunity.

[231]  W. L. Wong,et al.  Thyroid follicular cells produce interleukin-8. , 1992, The Journal of clinical endocrinology and metabolism.

[232]  H. Gerstein How common is postpartum thyroiditis? A methodologic overview of the literature. , 1990, Archives of internal medicine.

[233]  H. Inoko,et al.  Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations , 1992, Clinical endocrinology.

[234]  A. Pinchera,et al.  Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. , 1993, The Journal of clinical endocrinology and metabolism.

[235]  C. Lai,et al.  Effects of interferon-gamma therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. , 1990, The Journal of clinical endocrinology and metabolism.

[236]  L. Braverman,et al.  Methimazole and serum thyroid hormone concentrations in hyperthyroid patients: effects of single and multiple daily doses. , 1989, Annals of internal medicine.

[237]  A. Pinchera,et al.  Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. , 1993, The Journal of clinical endocrinology and metabolism.

[238]  S. McLachlan,et al.  TSH RECEPTOR ANTIBODY SYNTHESIS BY THYROID LYMPHOCYTES , 1986, Clinical endocrinology.

[239]  P. Carayon,et al.  Significance of thyroglobulin antibodies cross‐reactive with thyroperoxidase (TGPO antibodies) in individual patients and immunized mice , 1993, Clinical and experimental immunology.

[240]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[241]  Postpartum thyroid dysfunction. , 1986, Archives of internal medicine.

[242]  L. Harrison,et al.  1 Overview: the major histocompatibility complex and insulin dependent diabetes mellitus , 1991 .

[243]  A. Weetman,et al.  Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease. , 1986, The Journal of clinical endocrinology and metabolism.

[244]  Y. Iwatani,et al.  Increase in peripheral large granular lymphocytes in postpartum autoimmune thyroiditis. , 1988, Endocrinologia japonica.

[245]  D. Russo,et al.  Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. , 1991, The Journal of biological chemistry.

[246]  D. Russo,et al.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[247]  H. Mashiba,et al.  The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies. , 1990, Endocrinology.

[248]  E. Milgrom,et al.  Cloning, sequencing and expression of human TSH receptor. , 1990, Biochemical and biophysical research communications.

[249]  Y. Tomer,et al.  Infection, thyroid disease, and autoimmunity. , 1993, Endocrine reviews.

[250]  J. Säfwenberg,et al.  Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. , 1985, The Journal of clinical endocrinology and metabolism.

[251]  O. Kämpe,et al.  Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. , 1990, The Journal of clinical endocrinology and metabolism.

[252]  C. Gorman,et al.  Increased induction of HLA-DR by interferon-gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy. , 1991, The Journal of clinical endocrinology and metabolism.

[253]  C. Marcocci,et al.  Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. , 1993, The Journal of clinical endocrinology and metabolism.

[254]  N. Niesen,et al.  Transfer of experimental autoimmune thyroiditis by in situ perfusion of thyroids with immune sera. , 1993, Clinical immunology and immunopathology.

[255]  D. Russo,et al.  Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding. , 1990, Biochemical and biophysical research communications.

[256]  K. Ito,et al.  Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action. , 1985, The Journal of clinical endocrinology and metabolism.

[257]  J. Romaldini,et al.  Graves’ disease and Hashimoto’s thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels , 1986, Journal of endocrinological investigation.

[258]  A. Weetman,et al.  Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. , 1992, Immunology.

[259]  N. Farid,et al.  Association between Graves' ophthalmopathy and smoking , 1990, The Lancet.

[260]  E. D. Williams,et al.  Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. , 1985, Acta endocrinologica.

[261]  A. Vladutiu Experimental autoimmune thyroiditis in mice chronically treated from birth with anti-IgM antibodies. , 1989, Cellular immunology.

[262]  J. Lanchbury,et al.  Antigen‐specific T cell recognition of affinity‐purified and recombinant thyroid peroxidase in autoimmune thyroid disease , 1992, Clinical and experimental immunology.

[263]  M. Wheeler,et al.  Extrathyroidal sites of autoantibody synthesis in Graves' disease. , 1984, Clinical and experimental immunology.

[264]  W. Cohen,et al.  Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. , 1992, The Journal of clinical investigation.

[265]  H. B. Machado,et al.  Long-term amiodarone therapy and antithyroid antibodies. , 1992, The American journal of cardiology.

[266]  W. McKenna,et al.  Amiodarone and thyroid autoimmunity in the United Kingdom. , 1988, BMJ.

[267]  M. L. Santos,et al.  Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. , 1986, British medical journal.

[268]  A. Weetman,et al.  Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid‐associated ophthalmopathy , 1994, Clinical endocrinology.

[269]  J. Mckenzie,et al.  Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. , 1990, The Journal of clinical endocrinology and metabolism.

[270]  M. Burr,et al.  The prevalence and progression of autoimmune thyroid disease in the elderly. , 1984, Acta endocrinologica.

[271]  O. Pryds,et al.  HLA-DR factors associated with postpartum hypothyroidism: an early manifestation of Hashimoto's thyroiditis? , 2008, Tissue antigens.

[272]  Y. Iwatani,et al.  IN‐VITRO CONVERSION OF BLOCKING TYPE ANTI‐TSH RECEPTOR ANTIBODY TO THE STIMULATING TYPE BY ANTI‐HUMAN IgG ANTIBODIES , 1987, Clinical endocrinology.

[273]  S. Swillens,et al.  Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein. , 1992, The Journal of clinical endocrinology and metabolism.

[274]  J. Mckenzie,et al.  The effect of thyroxine on spontaneous thyroiditis in BB/W rats. , 1988, International Archives of Allergy and Applied Immunology.

[275]  P. Young,et al.  The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. , 1988, Clinical and experimental immunology.

[276]  A. Ahmann,et al.  Immunoglobulin and T cell antigen receptor gene arrangements indicate that the immune response in autoimmune thyroid disease is polyclonal. , 1988, The Journal of clinical endocrinology and metabolism.

[277]  G. Kroemer,et al.  Disturbed immune regulation in spontaneous autoimmune thyroiditis. , 1988, Concepts in immunopathology.

[278]  A. Cooke,et al.  Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells , 1991, The Journal of experimental medicine.

[279]  L. Degroot,et al.  Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. , 1991, The Journal of clinical endocrinology and metabolism.

[280]  N. Farid,et al.  ASSOCIATION OF GOITROUS AUTOIMMUNE THYROIDITIS WITH HLA‐DR3 IN EASTERN HUNGARY , 1987, Journal of immunogenetics.

[281]  P. Laurberg,et al.  The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. , 1987, Acta endocrinologica. Supplementum.

[282]  T. Hashimoto,et al.  Iodine-induced hypothyroidism: a clinical and histological study of 28 patients. , 1993, The Journal of clinical endocrinology and metabolism.

[283]  S. Ratanachaiyavong,et al.  7 Immunosuppressive effects of antithyroid drugs , 1985 .

[284]  G. Nabozny,et al.  Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta. , 1992, Journal of immunology.

[285]  M. Shong,et al.  The IgG subclass distribution of TSH receptor blocking antibodies in primary hypothyroidism , 1992, Clinical endocrinology.

[286]  C. Darke,et al.  Postpartum thyroid dysfunction and HLA status , 1990, European journal of clinical investigation.

[287]  S. Ratanachaiyavong,et al.  Prediction of outcome in Graves' disease after carbimazole treatment. , 1986, The Quarterly journal of medicine.

[288]  J. Franklyn,et al.  HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis , 1992, Clinical endocrinology.